Contact Us
Contact Us

At Fluxion, we’re passionate about delivering cell-based and cell-free solutions that facilitate the transformation of research discoveries into new ways to diagnose and treat patients. By characterizing molecular and cellular mechanisms of disease, Fluxion’s platforms help bridge the translational medicine gap, enabling rapid advances in disease research, drug discovery, and the development of diagnostic tests.

The interaction between anti-PF4 antibodies and anticoagulants in vaccine-induced thrombotic thrombocytopenia

Picture of Fluxion Biosciences Fluxion Biosciences Mar 25, 2022 5:20:00 PM

COVID-19 Thrombosis Article Cellular Analysis

ACCESS TO ARTICLE →